PPT Slide

Solubility

• Major problem for new compounds

• Nanoparticle enhanced solubility
  • Medac GmbH acquired 1999
  • New, expanded Swiss facility opened April 2001
  • August 2001: strategic investment in RTP Pharma Inc (Montreal, Canada): leader in solving the insolubility problem - IDD™ technology
    • Late-stage proprietary pipeline
      • 1 filed; 1 Phase II
    • Complementary:
      • third part clients (Schering Plough Group, SuperGen, IDEXX)
      • SkyePharma technologies
    • Few competitors
    • Baxter relationship

Previous slide

Next slide

Back to first slide

View graphic version